GlaxoSmithKline Inc., in consultation with Health Canada, is voluntarily recalling two lots of “IMITREX Injection”, a migraine medication packaged in pre-filled syringes with an accompanying sterile needle for injection. The needles come with plastic shields that are designed to keep them free of contamination. Needles in the affected lots may be protruding through the needle shield.
The protruding needle is no longer sterile and as such, there is a potential risk of infection to consumers when using the product.
Consumers who have used or are using any product from the two affected lots (see above).
Health Canada is monitoring the recall of “IMITREX Injection” by
GSK.
Consumers and health professionals wanting more information about this advisory from Health Canada can contact the Public Enquiries Line at 613-957-2991, or toll free at 1-866-225-0709.
Media enquiries related to this Advisory should be directed to Health Canada Media Relations at 613-957-2983.
Media Enquiries:
Health Canada
(613) 957-2983
Public Enquiries:
(613) 957-2991
1-866 225-0709